hu.MAP 2.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: HuMAP2_02295
Confidence: Medium High  
ProteinsGenename | Protein Name | Links |
---|---|---|
BCL2L1 | Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X) | UniProt   NCBI |
BAD | Bcl2-associated agonist of cell death (BAD) (Bcl-2-binding component 6) (Bcl-2-like protein 8) (Bcl2-L-8) (Bcl-xL/Bcl-2-associated death promoter) (Bcl2 antagonist of cell death) | UniProt   NCBI |
TRMO | tRNA (adenine(37)-N6)-methyltransferase (EC 2.1.1.-) (tRNA methyltransferase O) | UniProt   NCBI |
BCL2L11 | Bcl-2-like protein 11 (Bcl2-L-11) (Bcl2-interacting mediator of cell death) | UniProt   NCBI |
BCL2 | Apoptosis regulator Bcl-2 | UniProt   NCBI |
RHPN2 | Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE) | UniProt   NCBI |
Enrichments
Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
---|---|---|---|---|
  REAC:R-HSA-111453 | 1.51091283076e-10 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members |
  REAC:R-HSA-109606 | 2.74945671388e-07 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | Intrinsic Pathway for Apoptosis |
  WP:WP254 | 3.26731768958e-07 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | Apoptosis |
  KEGG:01521 | 3.86936610311e-07 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | EGFR tyrosine kinase inhibitor resistance |
  WP:WP1772 | 4.9900117021e-07 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | Apoptosis Modulation and Signaling |
  KEGG:04210 | 3.24115048953e-06 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | Apoptosis |
  KEGG:04215 | 6.80039367008e-06 | 0.5 | BCL2L11 BCL2 BCL2L1 | Apoptosis - multiple species |
  WP:WP2447 | 1.25967140138e-05 | 0.5 | BAD BCL2 BCL2L1 | Amyotrophic lateral sclerosis (ALS) |
  WP:WP286 | 1.7131668569e-05 | 0.5 | BAD BCL2 BCL2L1 | IL-3 Signaling Pathway |
  REAC:R-HSA-114452 | 2.40800825039e-05 | 0.5 | BCL2L11 BCL2 BAD | Activation of BH3-only proteins |
  WP:WP3611 | 2.41794273383e-05 | 0.5 | BCL2L11 BCL2 BCL2L1 | Photodynamic therapy-induced AP-1 survival signaling. |
  GO:2001244 | 2.99853000209e-05 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | positive regulation of intrinsic apoptotic signaling pathway |
  KEGG:05014 | 3.4770637772e-05 | 0.5 | BAD BCL2 BCL2L1 | Amyotrophic lateral sclerosis (ALS) |
  REAC:R-HSA-109581 | 3.86525710038e-05 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | Apoptosis |
  REAC:R-HSA-5357801 | 4.14836354799e-05 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | Programmed Cell Death |
  GO:0001836 | 4.49707918505e-05 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | release of cytochrome c from mitochondria |
  REAC:R-HSA-844455 | 6.65030189148e-05 | 0.333333333333 | BCL2 BCL2L1 | The NLRP1 inflammasome |
  WP:WP4172 | 8.1191833253e-05 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | PI3K-Akt Signaling Pathway |
  WP:WP4216 | 8.49189157531e-05 | 0.5 | BCL2L11 BCL2 BAD | Chromosomal and microsatellite instability in colorectal cancer |
  KEGG:01524 | 9.92621413242e-05 | 0.5 | BAD BCL2 BCL2L1 | Platinum drug resistance |
  KEGG:04151 | 0.00010854557604 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | PI3K-Akt signaling pathway |
  KEGG:05210 | 0.000147172017102 | 0.5 | BCL2L11 BCL2 BAD | Colorectal cancer |
  GO:0046902 | 0.000154355035659 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | regulation of mitochondrial membrane permeability |
  KEGG:05145 | 0.000222353816754 | 0.5 | BAD BCL2 BCL2L1 | Toxoplasmosis |
  GO:0090559 | 0.000246130343849 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | regulation of membrane permeability |
  WP:WP710 | 0.000269213029719 | 0.5 | BCL2L11 BCL2 BAD | DNA Damage Response (only ATM dependent) |
  KEGG:05162 | 0.000563363106539 | 0.5 | BAD BCL2 BCL2L1 | Measles |
  KEGG:05200 | 0.000619708787865 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | Pathways in cancer |
  KEGG:04140 | 0.000632078586851 | 0.5 | BAD BCL2 BCL2L1 | Autophagy - animal |
  WP:WP3657 | 0.000852627081304 | 0.333333333333 | BCL2 BCL2L1 | Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex |
  GO:0008637 | 0.000968898210955 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | apoptotic mitochondrial changes |
  WP:WP3872 | 0.00105843860426 | 0.333333333333 | BCL2 BCL2L1 | Regulation of Apoptosis by Parathyroid Hormone-related Protein |
  MIRNA:hsa-miR-16-1-3p | 0.00127334227449 | 0.5 | BCL2L11 BCL2 TRMO | hsa-miR-16-1-3p |
  WP:WP205 | 0.00128637745568 | 0.333333333333 | BCL2L1 BAD | IL-7 Signaling Pathway |
  GO:2001235 | 0.00193921959428 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | positive regulation of apoptotic signaling pathway |
  GO:0007006 | 0.00201287714577 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | mitochondrial membrane organization |
  GO:2001242 | 0.00208860909913 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | regulation of intrinsic apoptotic signaling pathway |
  KEGG:05170 | 0.00211201253822 | 0.5 | BAD BCL2 BCL2L1 | Human immunodeficiency virus 1 infection |
  REAC:R-HSA-111447 | 0.00232260810736 | 0.333333333333 | BCL2 BAD | Activation of BAD and translocation to mitochondria |
  MIRNA:hsa-miR-3120-3p | 0.00238133708387 | 0.5 | BCL2L11 BCL2L1 RHPN2 | hsa-miR-3120-3p |
  WP:WP3981 | 0.00293450086565 | 0.333333333333 | BCL2 BAD | miRNA regulation of prostate cancer signaling pathways |
  GO:0005741 | 0.00317351526138 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | mitochondrial outer membrane |
  WP:WP3941 | 0.00369881973951 | 0.333333333333 | BCL2 BAD | Oxidative Damage |
  REAC:R-HSA-622312 | 0.00377982352449 | 0.333333333333 | BCL2 BCL2L1 | Inflammasomes |
  GO:0031968 | 0.00436089686659 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | organelle outer membrane |
  GO:0019867 | 0.00449563214179 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | outer membrane |
  WP:WP364 | 0.00477752328717 | 0.333333333333 | BCL2L1 BAD | IL-6 signaling pathway |
  WP:WP4008 | 0.0050096749716 | 0.333333333333 | BCL2 BAD | NO/cGMP/PKG mediated Neuroprotection |
  WP:WP1971 | 0.0050096749716 | 0.333333333333 | BCL2 BAD | Integrated Cancer Pathway |
  GO:0010821 | 0.00506594708818 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | regulation of mitochondrion organization |
  GO:0001844 | 0.00661098268806 | 0.5 | BCL2L11 BCL2 BAD | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway |
  WP:WP304 | 0.00852373853417 | 0.333333333333 | BCL2 BAD | Kit receptor signaling pathway |
  GO:0090199 | 0.0108183376095 | 0.5 | BCL2L11 BCL2L1 BAD | regulation of release of cytochrome c from mitochondria |
  KEGG:04115 | 0.0124835568261 | 0.333333333333 | BCL2 BCL2L1 | p53 signaling pathway |
  KEGG:05168 | 0.0142962779924 | 0.5 | BAD BCL2 BCL2L1 | Herpes simplex virus 1 infection |
  WP:WP2034 | 0.014901555017 | 0.333333333333 | BCL2L1 BAD | Leptin signaling pathway |
  WP:WP4298 | 0.0153070697985 | 0.333333333333 | BCL2 BCL2L1 | Viral Acute Myocarditis |
  KEGG:05212 | 0.0153684049392 | 0.333333333333 | BCL2L1 BAD | Pancreatic cancer |
  WP:WP1438 | 0.0166465613198 | 0.166666666667 | BCL2 | Influenza A virus infection |
  KEGG:05220 | 0.0166952607135 | 0.333333333333 | BCL2L1 BAD | Chronic myeloid leukemia |
  WP:WP4263 | 0.0187442252959 | 0.333333333333 | BCL2L1 BAD | Pancreatic adenocarcinoma pathway |
  KEGG:04064 | 0.0190270141569 | 0.333333333333 | BCL2 BCL2L1 | NF-kappa B signaling pathway |
  WP:WP673 | 0.0196570281132 | 0.333333333333 | BCL2L11 BAD | ErbB Signaling Pathway |
  GO:0051881 | 0.0207293189685 | 0.5 | BAD BCL2 BCL2L1 | regulation of mitochondrial membrane potential |
  WP:WP231 | 0.021066272601 | 0.333333333333 | BCL2L1 BAD | TNF alpha Signaling Pathway |
  GO:0070059 | 0.0222806450818 | 0.5 | BCL2L11 BCL2 BCL2L1 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
  GO:0097193 | 0.023174580771 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | intrinsic apoptotic signaling pathway |
  GO:0051204 | 0.0239073169747 | 0.5 | BCL2L11 BCL2 BAD | protein insertion into mitochondrial membrane |
  WP:WP4658 | 0.02454095485 | 0.333333333333 | BCL2 BCL2L1 | Small cell lung cancer |
  KEGG:05215 | 0.0246844798555 | 0.333333333333 | BCL2 BAD | Prostate cancer |
  KEGG:01522 | 0.0246844798555 | 0.333333333333 | BCL2 BAD | Endocrine resistance |
  KEGG:05222 | 0.0257907962007 | 0.333333333333 | BCL2 BCL2L1 | Small cell lung cancer |
  REAC:R-HSA-168643 | 0.0302745579484 | 0.333333333333 | BCL2 BCL2L1 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
  REAC:R-HSA-193648 | 0.0302745579484 | 0.333333333333 | BCL2L11 BAD | NRAGE signals death through JNK |
  GO:0097345 | 0.0312028564126 | 0.5 | BCL2L11 BCL2 BAD | mitochondrial outer membrane permeabilization |
  KEGG:04722 | 0.0348461971614 | 0.333333333333 | BCL2 BAD | Neurotrophin signaling pathway |
  GO:1902110 | 0.0353486827187 | 0.5 | BCL2L11 BCL2 BAD | positive regulation of mitochondrial membrane permeability involved in apoptotic process |
  GO:0006839 | 0.0364891183251 | 0.666666666667 | BCL2L11 BAD BCL2 BCL2L1 | mitochondrial transport |
  MIRNA:hsa-miR-184 | 0.0388499553328 | 0.333333333333 | BCL2 BCL2L1 | hsa-miR-184 |
  GO:1902686 | 0.0398453744123 | 0.5 | BCL2L11 BCL2 BAD | mitochondrial outer membrane permeabilization involved in programmed cell death |
  GO:0051400 | 0.0405595771497 | 0.333333333333 | BCL2 BCL2L1 | BH domain binding |
  GO:0051434 | 0.0405595771497 | 0.333333333333 | BCL2 BCL2L1 | BH3 domain binding |
  GO:0035794 | 0.0422297014162 | 0.5 | BCL2L11 BCL2 BAD | positive regulation of mitochondrial membrane permeability |
  GO:0051205 | 0.0422297014162 | 0.5 | BCL2L11 BCL2 BAD | protein insertion into membrane |
  GO:1902108 | 0.0422297014162 | 0.5 | BCL2L11 BCL2 BAD | regulation of mitochondrial membrane permeability involved in apoptotic process |
  KEGG:04630 | 0.0444979624084 | 0.333333333333 | BCL2 BCL2L1 | JAK-STAT signaling pathway |
  GO:1905710 | 0.0447070305646 | 0.5 | BCL2L11 BCL2 BAD | positive regulation of membrane permeability |
  REAC:R-HSA-204998 | 0.0499130144295 | 0.333333333333 | BCL2L11 BAD | Cell death signalling via NRAGE, NRIF and NADE |
  CORUM:7275 | 0.0499726005494 | 0.166666666667 | BCL2 | BCL2-CISD2 complex |
  CORUM:1062 | 0.0499726005494 | 0.166666666667 | BCL2 | BAR-BCL2-CASP8 complex |
  CORUM:5526 | 0.0499726005494 | 0.166666666667 | BCL2 | CALM1-FKBP38-BCL2 complex |
  CORUM:5811 | 0.0499726005494 | 0.166666666667 | BCL2 | p53-BCL2 complex |
  CORUM:5812 | 0.0499726005494 | 0.166666666667 | BCL2L1 | p53-BCL2 complex |
Edges
Protein 1 | Protein 2 | Score | Precision | Evidence |
---|---|---|---|---|
 BAD |  BCL2L1 | 0.976 | 0.892           | bioplex (BCL2L1)     bioplex_WMM     |
 BCL2 |  BCL2L1 | 0.831 | 0.778           | bioplex (BCL2L1)     bioplex_WMM     |
 BCL2L11 |  BCL2L1 | 0.773 | 0.752           | bioplex (BCL2L1,BCL2L11)     bioplex_WMM     |
 BCL2L11 |  RHPN2 | 0.731 | 0.736           | bioplex (BCL2L11)     bioplex_WMM     |
 RHPN2 |  TRMO | 0.149 | 0.41           | bioplex (TRMO)     bioplex_WMM     |
 BCL2 |  BCL2L11 | 0.066 | 0.35           | bioplex (BCL2L11)     bioplex_WMM     |
 BAD |  BCL2 | 0.009 | 0.101           | bioplex_WMM     WMM_only     |
 BCL2 |  RHPN2 | 0.009 | 0.096           | bioplex_WMM     WMM_only     |
 BCL2L1 |  RHPN2 | 0.009 | 0.098           | bioplex_WMM     WMM_only     |
 BAD |  BCL2L11 | 0.008 | 0.068           | bioplex_WMM     WMM_only     |
Images
Click to enlarge

Complex HuMAP2_02295 has an average edge precision of 0.428 which is ranked 3042 out of all 6965 complexes.
Related Complexes